CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Consano Bio Announces Peer-Reviewed Publication Supporting the Therapeutic Potential of C-1101 in Chronic, Painful Lumbosacral Radiculopathy (LSR) or Chronic Sciatica

C-1101Positive
AI Analysis

Summary

Consano Bio announced a peer-reviewed publication in Frontiers in Bioengineering and Biotechnology showing C-1101 reduced inflammation and activated repair pathways in a nonclinical study for chronic lumbosacral radiculopathy.

Outcome Details

Peer-reviewed publication in Frontiers in Bioengineering and Biotechnology demonstrating C-1101 reduced inflammation and tissue breakdown while activating repair pathways in nonclinical study

Importance:3/10
Sentiment:
0.60
PublicationNonclinical dataInflammatory painMechanism of action

Read the original article

Published by PR Newswire Clinical Trials on September 10, 2026 12:10 PM

Read Original